CLINICAL_TRIALS
trial_result
· 2023-01-23
Clinical Trial Update: Contrast Ultrasound Detection of Sentinel Lymph Nodes [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating contrast-enhanced ultrasound for detection of sentinel lymph nodes in breast cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED